Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Positive nonsentinel node status predicts mortality in patients with cutaneous melanoma.

Ariyan C, Brady MS, Gönen M, Busam K, Coit D.

Ann Surg Oncol. 2009 Jan;16(1):186-90. doi: 10.1245/s10434-008-0187-5. Epub 2008 Nov 1.

PMID:
18979135
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma.

Ghaferi AA, Wong SL, Johnson TM, Lowe L, Chang AE, Cimmino VM, Bradford CR, Rees RS, Sabel MS.

Ann Surg Oncol. 2009 Nov;16(11):2978-84. doi: 10.1245/s10434-009-0665-4. Epub 2009 Aug 27.

PMID:
19711133
[PubMed - indexed for MEDLINE]
3.

Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study.

Pasquali S, Mocellin S, Mozzillo N, Maurichi A, Quaglino P, Borgognoni L, Solari N, Piazzalunga D, Mascheroni L, Giudice G, Patuzzo R, Caracò C, Ribero S, Marone U, Santinami M, Rossi CR.

J Clin Oncol. 2014 Mar 20;32(9):935-41. doi: 10.1200/JCO.2013.50.7681. Epub 2014 Feb 10.

PMID:
24516022
[PubMed - indexed for MEDLINE]
4.

Staging of regional lymph nodes in melanoma: a case for including nonsentinel lymph node positivity in the American Joint Committee on Cancer staging system.

Leung AM, Morton DL, Ozao-Choy J, Hari DM, Shin-Sim M, Difronzo AL, Faries MB.

JAMA Surg. 2013 Sep;148(9):879-84. doi: 10.1001/jamasurg.2013.3044.

PMID:
23903435
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma.

Gyorki DE, Boyle JO, Ganly I, Morris L, Shaha AR, Singh B, Wong RJ, Shah JP, Busam K, Kraus D, Coit DG, Patel S.

Eur J Surg Oncol. 2014 Mar;40(3):305-10. doi: 10.1016/j.ejso.2013.11.017. Epub 2013 Dec 13.

PMID:
24361245
[PubMed - indexed for MEDLINE]
6.

Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma.

Sabel MS, Griffith K, Sondak VK, Lowe L, Schwartz JL, Cimmino VM, Chang AE, Rees RS, Bradford CR, Johnson TM.

J Am Coll Surg. 2005 Jul;201(1):37-47.

PMID:
15978442
[PubMed - indexed for MEDLINE]
7.

Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?

Frankel TL, Griffith KA, Lowe L, Wong SL, Bichakjian CK, Chang AE, Cimmino VM, Bradford CR, Rees RS, Johnson TM, Sabel MS.

Ann Surg Oncol. 2008 Sep;15(9):2403-11. doi: 10.1245/s10434-008-0024-x. Epub 2008 Jul 15.

PMID:
18626721
[PubMed - indexed for MEDLINE]
8.

Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.

Roka F, Mastan P, Binder M, Okamoto I, Mittlboeck M, Horvat R, Pehamberger H, Diem E.

Eur J Surg Oncol. 2008 Jan;34(1):82-8. Epub 2007 Mar 13.

PMID:
17360144
[PubMed - indexed for MEDLINE]
9.

Prediction of nonsentinel lymph node status in melanoma.

Reeves ME, Delgado R, Busam KJ, Brady MS, Coit DG.

Ann Surg Oncol. 2003 Jan-Feb;10(1):27-31.

PMID:
12513956
[PubMed - indexed for MEDLINE]
10.

Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.

Page AJ, Carlson GW, Delman KA, Murray D, Hestley A, Cohen C.

Am Surg. 2007 Jul;73(7):674-8; discussion 678-9.

PMID:
17674939
[PubMed - indexed for MEDLINE]
11.

Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.

Rossi CR, De Salvo GL, Bonandini E, Mocellin S, Foletto M, Pasquali S, Pilati P, Lise M, Nitti D, Rizzo E, Montesco MC.

Ann Surg Oncol. 2008 Apr;15(4):1202-10. doi: 10.1245/s10434-007-9734-8. Erratum in: Ann Surg Oncol. 2008 May;15(5):1552.

PMID:
18165880
[PubMed - indexed for MEDLINE]
12.

Accuracy of the non-sentinel node risk score (N-SNORE) in patients with cutaneous melanoma and positive sentinel lymph nodes: a retrospective study.

Feldmann R, Fink AM, Jurecka W, Rappersberger K, Steiner A.

Eur J Surg Oncol. 2014 Jan;40(1):73-6. doi: 10.1016/j.ejso.2013.08.022. Epub 2013 Sep 12.

PMID:
24075029
[PubMed - indexed for MEDLINE]
13.

Criteria in sentinel lymph nodes of melanoma patients that predict involvement of nonsentinel lymph nodes.

Satzger I, Völker B, Meier A, Kapp A, Gutzmer R.

Ann Surg Oncol. 2008 Jun;15(6):1723-32. doi: 10.1245/s10434-008-9888-z. Epub 2008 Apr 4.

PMID:
18389323
[PubMed - indexed for MEDLINE]
14.

The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.

Zdzienicki M, Rutkowski P, Nowecki ZI, van Akkooi AC, Michej W, Dziewirski W, Świtaj T, Pieńkowski A, Sałamacha M, Bylina E, Eggermont AM.

Eur J Surg Oncol. 2013 Mar;39(3):304-10. doi: 10.1016/j.ejso.2012.12.014. Epub 2013 Jan 5.

PMID:
23298828
[PubMed - indexed for MEDLINE]
15.

Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes--one institution's experience.

Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W.

Melanoma Res. 2003 Feb;13(1):35-43.

PMID:
12569283
[PubMed - indexed for MEDLINE]
16.

Sentinel lymph node staging of cutaneous melanoma: predictors and outcomes.

Ellis MC, Weerasinghe R, Corless CL, Vetto JT.

Am J Surg. 2010 May;199(5):663-8. doi: 10.1016/j.amjsurg.2010.01.019.

PMID:
20466113
[PubMed - indexed for MEDLINE]
17.

Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.

Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W.

Ann Surg Oncol. 2006 Dec;13(12):1655-63. Epub 2006 Oct 3.

PMID:
17016755
[PubMed - indexed for MEDLINE]
18.

Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.

Debarbieux S, Duru G, Dalle S, Béatrix O, Balme B, Thomas L.

Br J Dermatol. 2007 Jul;157(1):58-67. Epub 2007 May 14.

PMID:
17501957
[PubMed - indexed for MEDLINE]
19.

Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.

Callender GG, Egger ME, Burton AL, Scoggins CR, Ross MI, Stromberg AJ, Hagendoorn L, Martin RC 2nd, McMasters KM.

Am J Surg. 2011 Dec;202(6):659-64; discussion 664-5. doi: 10.1016/j.amjsurg.2011.06.048.

PMID:
22137134
[PubMed - indexed for MEDLINE]
20.

Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma.

Gershenwald JE, Mansfield PF, Lee JE, Ross MI.

Ann Surg Oncol. 2000 Mar;7(2):160-5.

PMID:
10761797
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk